✦ LIBER ✦

PCV34 A COST-EFFECTIVENESS ANALYSIS OF OLMESARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION

✍ Scribed by M Lamotte; L Annemans; R Van Loy; W Koch

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV22 COST EFFECTIVENESS ANALYSIS OF BOS

✍ TJ Lee; J Kim; HS Sohn; D Kim 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PCV88 THE COST EFFECTIVENESS OF AMBRISEN

✍ S Redmond; D Bozkaya 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PCV61 Pharmacoeconomic Evaluation of Olm

✍ S.G. Gorokhova; V.V. Ryazhenov 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PCV52 Urapidil in Treatment of Hypertens

✍ A. Kulikov; M. Protsenko; B. Misikova 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PCVI9 COST-EFFECTIVENESS ANALYSIS OF THE

✍ PC Stafilas; PA Sarafidis; AN Lasaridis; VH Aietras; MD Zouka 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

PCV21 COST-EFFECTIVENESS OF HYPERTENSION

✍ J Kyriopoulos; K Athanasakis; A Zavras; A Angeli; M Geitona 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB